cardiology

News in brief: NVAF patients on DOACs at lower stroke risk versus warfarin; Hydroxychloroquine CV risk re-assessed in non-COVID-19 patients; Cardiologist jailed

NVAF patients on DOACs at lower stroke risk versus warfarin Non-valvular atrial fibrillation (NAVF) patients with high risk of gastrointestinal (GI) bleed appear less likely to suffer stroke or systemic embolism (SE) while on non-vitamin K antagonist oral anticoagulants (DOACs) than warfarin, a study suggests. Published in JAMA Network Open, the study compared stroke and/or ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic